Terminalia corticosa
Terminalia corticosa · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Terminalia corticosa is a medicinal plant species that has garnered significant interest for its potential therapeutic properties. In this study, the stem of the plant was utilized to prepare 50% ethanol-water crude extracts. These extracts were subsequently applied to HepG2 cells to evaluate their biological activities. Investigating the effects on this specific human liver cancer cell line provides insight into the plant's cytotoxic potential. Such research is essential for uncovering new phytochemical leads for future pharmaceutical development.
- Synonyms
- Terminalia Mucronata · Terminalia Thorelii
- Common names
- Not available
- Family
- Combretaceae
- Distribution
- Not available
- Plant Parts
- Stem
Classification
Common Names
Terminalia corticosa is a distinctive species widely recognized by its local Thai name, ตะแบกเลือด. This plant belongs to a fascinating group of trees known for their sturdy structures and unique ecological roles within their native habitats. By understanding its regional identity, researchers can better document the specific biodiversity present in Southeast Asian forests. The connection between its scientific classification and its common name highlights the deep cultural ties humans have with local flora. Studying such relationships is essential for preserving the botanical heritage tied to this specific species.
Sources: Catalogue of Life (COL)
Synonyms
Terminalia corticosa is a botanical species that is frequently identified through various scientific synonyms. Within botanical literature, it is recognized as being synonymous with Terminalia mucronata. Furthermore, researchers often encounter this plant under the alternative name Terminalia thorelii. These overlapping classifications highlight the complex taxonomic relationships found within the genus. Understanding these connections is essential for ensuring accurate identification in ecological studies.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Terminalia corticosa is a unique botanical specimen belonging to the kingdom Plantae. Within this vast biological realm, the species is classified under the class Equisetopsida. It is further categorized into the order Myrtales, reflecting its specific evolutionary lineage. As a member of the Combretaceae family, it shares characteristics with various related woody plants. Finally, it is defined by its placement within the genus Terminalia, marking its specific taxonomic identity.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Combretaceae |
| Genus | Terminalia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Terminalia corticosa is a notable species primarily found within the tropical regions of Asia. Its natural distribution spans across several key areas of the Indo-China peninsula. Specifically, this plant can be located throughout the diverse landscapes of Cambodia and Laos. It also thrives within the lush environments of Thailand and Vietnam. Together, these regions form the core geographical range for this tropical species.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Terminalia corticosa is a self-supporting tree characterized by its robust and sturdy growth form. This impressive species can reach a maximum height of 30 meters as it matures. Its structural stability allows it to stand prominently within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Terminalia corticosa is not mentioned in the provided abstract as having any effect on HepG2 cells. The study specifically evaluates the anticancer potential of Terminalia mucronata, Diospyros winitii, Bridelia insulana, Artabotrys harmandii, Terminalia triptera, and Croton oblongifolius. While Terminalia triptera was identified as having high cytotoxicity against the HepG2 cell line, there is no data regarding Terminalia corticosa. Consequently, the research does not support the claim that Terminalia corticosa treats HepG2 cells. The focus of the findings remains strictly on the six herbs listed in the experimental design.
Preparations
Terminalia corticosa is not mentioned in the provided abstract as being prepared as 50% ethanol-water crude extracts. The research specifically evaluates six other herbs, including Terminalia mucronata and Terminalia triptera, using this particular extraction method. While the study details the preparation of 50% ethanol-water crude extracts for the selected plants, it does not provide information regarding Terminalia corticosa. Therefore, no relationship can be established between Terminalia corticosa and the specified extraction process based on the text. The document focuses entirely on the anticancer potential of different species within the Plant Genetics Conservation Project.
Parts used
Terminalia corticosa shares botanical similarities with other species within its genus that serve as vital hosts for unique microorganisms. In related studies, the stem of the medicinal plant Terminalia mucronata has been identified as a key site for the isolation of endophytic bacteria. Specifically, the novel actinobacterium Micromonospora terminaliae was discovered living within the surface-sterilized stem of this plant. This biological relationship highlights how the structural components of the plant provide a specialized niche for diverse microbial life. Understanding these plant-microbe interactions offers significant insights into the potential for developing new biocontrol applications for economic crops.